Search Within

Joseph G Jurcic

Formats
  1. Meeting Abstract (69)
  2. Journal Article (60)
  3. Book Section (3)
  4. Conference Paper (2)
Groups
  1. Department of Medicine (134)
  2. Hematologic Malignancies, Division of (134)
  3. Center for Hematologic Malignancies (112)
  4. Adult Leukemia (109)
  5. GSK Faculty (99)
  6. Hematologic Malignancies Research (95)

More Groups

People
  1. David Scheinberg (84)
  2. Peter Maslak (44)
  3. Steven Larson (33)
  4. Ronald Finn (26)
  5. Mark Heaney (23)
  6. Michael Mcdevitt (23)

More People

Years
  1. 2018 (1)
  2. 2016 (1)
  3. 2014 (2)
  4. 2013 (4)
  5. 2012 (9)
  6. 2011 (13)

More Years

Publications
  1. Blood (47)
  2. Journal of Clinical Oncology (13)
  3. Journal of Nuclear Medicine (8)
  4. Cancer Biotherapy and Radiopharmaceuticals (6)
  5. Cancer Chemotherapy and Biological Response Modifiers (4)
  6. Clinical Cancer Research (4)

More Publications

Publishers
  1. American Society of Hematology (48)
  2. American Society of Clinical Oncology (13)
  3. Elsevier Inc. (12)
  4. Society of Nuclear Medicine (8)
  5. Mary Ann Liebert, Inc (6)
  6. Springer (6)

More Publishers

Results (134)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: Specific targeting without immunogenicity
    Journal Article

    Caron, P. C.; Jurcic, J. G.; Scott, A. M.; Finn, R. D.; Divgi, C. R.; Graham, M. C.; Jureidini, I. M.; Sgouros, G.; Tyson, D.; Old, L. J.; more...
    Blood (1994)

    Fulltext@MSK | Save
  • (131)I-labeled anti-CD33 ((131)I-M195) may prolong disease-free survival (DFS) in relapsed acute promyelocytic leukemia (APL) after remission induction with all-trans retinoic acid (RA)
    Meeting Abstract

    Jurcic, J. G.; Caron, P. C.; Miller, W. H. Jr; Yao, T. J.; Maslak, P.; Finn, R.; Larson, S. M.; Warrell, R. P. Jr; Scheinberg, D. A.
    Blood (1993)

    Fulltext@MSK | Save
  • Results of allogeneic bone marrow transplant following (131)I-M195/busulfan/cyclophosphamide (BU/CY) in patients with advanced/refractory myeloid malignancies
    Meeting Abstract

    Papadopoulos, E. B.; Caron, P.; Castro-Malaspina, H.; Childs, B.; Mackinnon, S.; Young, J. W.; Jurcic, J.; Finn, R.; Larson, S.; O'Reilly, R. J.; more...
    Blood (1993)

    Fulltext@MSK | Save
  • Monoclonal antibody therapy of cancer
    Journal Article

    Jurcic, J. G.; Scheinberg, D. A.; Houghton, A. N.
    Cancer Chemotherapy and Biological Response Modifiers (1993)

    Fulltext@MSK | Save